Audit 339326

FY End
2024-06-30
Total Expended
$51.45M
Findings
0
Programs
34
Year: 2024 Accepted: 2025-01-22

Organization Exclusion Status:

Checking exclusion status...

Findings

No findings recorded

Programs

ALN Program Spent Major Findings
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $713,921 Yes 0
93.307 Minority Health and Health Disparities Research $577,519 Yes 0
93.959 Block Grants for Prevention and Treatment of Substance Abuse $540,611 Yes 0
93.846 Arthritis, Musculoskeletal and Skin Diseases Research $474,381 Yes 0
93.838 Maternal Microbial Metabolites $465,814 Yes 0
93.864 Hyperglycemic Memory on Innate Immune Response $416,798 Yes 0
93.859 Biomedical Research and Research Training $407,243 Yes 0
93.396 Cancer Biology Research $346,429 Yes 0
93.000 Healthy Decisions $281,764 Yes 0
93.226 Research on Healthcare Costs, Quality and Outcomes $267,390 Yes 0
93.393 Cancer Cause and Prevention Research $156,492 Yes 0
93.397 Cancer Centers Support Grants $145,094 Yes 0
93.866 Aging Research $123,455 Yes 0
98.001 Usaid Foreign Assistance for Programs Overseas $116,131 Yes 0
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $114,159 Yes 0
93.350 National Center for Advancing Translational Sciences $110,799 Yes 0
93.000 Cervical Cancer Cds Pilot $104,386 Yes 0
93.103 Food and Drug Administration Research $101,900 Yes 0
93.433 Acl National Institute on Disability, Independent Living, and Rehabilitation Research $53,429 Yes 0
93.000 Contraceptive Development Program $51,318 Yes 0
93.113 Environmental Health $45,734 Yes 0
93.310 Trans-Nih Research Support $40,861 Yes 0
93.865 Child Health and Human Development Extramural Research $28,087 Yes 0
93.395 Cancer Treatment Research $25,924 Yes 0
93.865 Covid-19 Child Health and Human Development Extramural Research $23,015 Yes 0
93.000 Intra-Operative Sampling of Fallopian Tubes $17,642 Yes 0
93.394 Cancer Detection and Diagnosis Research $15,637 Yes 0
93.279 Drug Abuse and Addiction Research Programs $11,660 Yes 0
12.420 Covid-19 Military Medical Research and Development $5,469 Yes 0
93.855 Allergy and Infectious Diseases Research $4,295 Yes 0
93.000 Dartmouth College Relief $1,835 Yes 0
12.420 Military Medical Research and Development $483 Yes 0
93.837 Cardiovascular Diseases Research $54 Yes 0
93.351 Research Infrastructure Programs $-1,526 Yes 0

Contacts

Name Title Type
J3Z5MNJJ3FZ4 Timothy Bell Auditee
4126416091 Elizabeth E. Krisher Auditor
No contacts on file

Notes to SEFA

Title: Basis of Presentation Accounting Policies: Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Negative amounts shown on the Schedule represent adjustments or credits made in the normal course of business to amounts reported as expenditures in prior years. De Minimis Rate Used: N Rate Explanation: MWRIF has elected to not use the 10-percent de minimis indirect cost rate as allowed under the Uniform Guidance. The accompanying schedule of expenditures of federal awards (Schedule) includes the federal award activity of Magee-Womens Research Institute and Foundation (MWRIF) under programs of the federal government for the year ended June 30, 2024. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of MWRIF, it is not intended to and does not present the financial position, changes in net assets, or cash flows of MWRIF.